Alan Brochstein

Earlier this month, Aurora Cannabis (NASDAQ: ABC) reported its second-quarter financial results, revealing a 10% decline in total net revenue, which totaled slightly over $60 million, and a $75.1 million loss. The company’s CEO Miguel Martin touted a sequential improvement of $2.5 million in...

After a rough start in 2022, cannabis stocks seem to have bounced back quickly to become the best performers year-to-date, outpacing the broader stock market or other high-risk sectors. During the first four weeks of 2022, cannabis stocks declined 18.4% in the New Cannabis Ventures Global...

Alan Brochstein, author of 420 Investor and founding partner of New Cannabis Ventures, says the recent political momentum behind the cannabis legalization push in the US — and the resulting rebound in cannabis stocks since the U.S. election — has him feeling extremely optimistic...

Several cannabis companies such as Canopy Growth Corp. (NYSE: CGC), Tilray Inc. (NASDAQ: TLRY) and Aurora Cannabis Inc. (NYSE: ACB) kicked off the week with an uptick in their respective stock prices. Alan Brochstein, founder of 420 Investor and New Cannabis Ventures, says there are "two...

Some of the most high-profile cannabis analysts shared their insights in a thrilling discussion about trends, strategies and forecasts at the Virtual Benzinga Cannabis Capital Conference. Alan Brochstein, the founder of 420 Investor and New Cannabis Ventures, led the discussion. Cresco, Green Thumb...

Aurora Cannabis Inc (NYSE: ACB)(TSE:ACB) reported a 35% sequential sales increase for the third quarter to far exceed analyst expectations. While its EBITDA loss was about $10 million worse than consensus forecasted, international medical sales and Canadian recreational sales beat estimates,...

As shelter-in-place orders drag on and the U.S. economy limps through the second quarter, investors, economists and politicians are asking important questions about what the post-outbreak economy will look like and how quickly the U.S. can replace the 26 million jobs it has lost in 2020. Many...

Big cannabis stocks are rallying on Monday, with many posting double-digits gains. So what’s going on? Alan Brochstein, author of the 420 Investor and founder of New Cannabis Ventures, said the move "seems driven by Canadian LPs, and some of that may be short-covering." If what we...

Alan Brochstein, founder of 420 Investor and New Cannabis Ventures, joined Benzinga’s PreMarket Prep show Monday to discuss how the cannabis industry and its main players are navigating the looming recession. In recent weeks, some financial commentators have viewed the recent...

It has been a brutal couple of years for cannabis investors. With most leading stocks down even further since the COVID-19 outbreak, cannabis investors are now weighing whether to cut their losses or buy the dip in a bet on a rebound ahead. Alan Brochstein, author of the 420 Investor and founding...

Tilray Inc (NASDAQ: TLRY) shares are trading sharply higher potentially on a rebound following weakness in the sector. A DataTrek report suggested the negative impact from the coronavirus could accelerate legalization as states look for ways to recoup losses. The Canadian cannabis cultivator’...

The big news on Thursday is Morgan Stanley’s (NYSE: MS) deal to acquire E*Trade Financial Corp (NASDAQ: ETFC) for $13 billion, or $58.74 per share. This marks the second major acquisition on the retail brokerage industry in the last four months, to go along with Charles Schwab’s (NYSE:...

It has been a brutal year for cannabis investors. Heading into 2020, cannabis investors are now weighing whether to cut their losses or buy the dip in a bet on a rebound ahead. Alan Brochstein, author of the 420 Investor and founding partner of New Cannabis Ventures, recently discussed his outlook...

Thursday marked the one-year anniversary of the legalization of recreational marijuana in Canada. Legalization hasn't translated into the end of the illicit market, and the price differences between the legal and illegal markets are substantial.  Legally accredited cannabis...

Oct. 17 marks one full year of legalized cannabis in Canada — and the road to this moment could have been smoother. “Canada’s rollout of legalization has been hampered by a number of things,” Alan Brochstein, author of 420 Investor, said this week on Benzinga’s...